BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10851917)

  • 1. [What do health professionals ask RELIS Vest service and how satisfied are they with the answers?].
    Schjøtt J; Pomp E; Gedde-Dahl A; Hundal O; Dybendal T; Opedal K
    Tidsskr Nor Laegeforen; 2000 Jan; 120(2):204-7. PubMed ID: 10851917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Questions about complementary and alternative medicine to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): a descriptive pilot study.
    Schjøtt J; Erdal H
    BMC Complement Altern Med; 2014 Feb; 14():56. PubMed ID: 24529279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Improved information on drugs to patients. A project with a pharmacist in the therapeutic team at a cardiology department].
    Veggeland T
    Tidsskr Nor Laegeforen; 1996 Jun; 116(16):1901-3. PubMed ID: 8711706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
    Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quality assurance audit of a drug information service.
    Johnson N; Dupuis LL
    Can J Hosp Pharm; 1989 Apr; 42(2):57-61. PubMed ID: 10292922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Problem-oriented drug information: the RELIS database, a free drug information on the Internet for Scandinavian health professionals].
    Mehlum LI; Frost SK
    Ugeskr Laeger; 2004 Aug; 166(34):2886-7. PubMed ID: 15449525
    [No Abstract]   [Full Text] [Related]  

  • 7. Quality and impact of problem-oriented drug information: a method to change clinical practice among physicians?
    Schjøtt J; Pomp E; Gedde-Dahl A
    Eur J Clin Pharmacol; 2002 Feb; 57(12):897-902. PubMed ID: 11936710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the quality of pharmacist answers to telephone drug information questions.
    Woodward CT; Stevenson JG; Poremba A
    Am J Hosp Pharm; 1990 Apr; 47(4):798-9. PubMed ID: 2321656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of patient-specific computer-generated drug information monographs.
    Groh HL; Peters LL; Young WW
    Hosp Pharm; 1987 May; 22(5):470-3, 479-82, 489-92 passim. PubMed ID: 10282252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing whether a clinical pharmacy program is meeting its goals.
    Fink A; Kosecoff J; Oppenheimer PR; Smith WE; Brodie DC
    Am J Hosp Pharm; 1982 May; 39(5):806-10. PubMed ID: 7081251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicians' questions concerning drug use among older patients: experience from Norwegian drug information centres (RELIS) in the period 2010-2015.
    Schjøtt J
    Aging Clin Exp Res; 2018 Jul; 30(7):867-870. PubMed ID: 28929445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [RELIS--a Norwegian database with free, problem-based drug information for health care].
    Frost S; Mehlum LI
    Lakartidningen; 2003 Sep; 100(38):2957. PubMed ID: 14558219
    [No Abstract]   [Full Text] [Related]  

  • 13. Attitudes of physicians toward formularies and services provided by pharmacists.
    Sansgiry SS; Hayes JD; Rice GK
    Manag Care Interface; 2003 Feb; 16(2):34-8. PubMed ID: 12647524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community, hospital and clinical pharmacists and drug information centers as physician drug information sources.
    Shearer SW; Gagnon JP; Eckel FM
    Am J Hosp Pharm; 1978 Aug; 35(8):909-14. PubMed ID: 677136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of an evidence-based answering service on GPs and their patients: a pilot study.
    Verhoeven AA; Schuling J
    Health Info Libr J; 2004 Sep; 21 Suppl 2():27-35. PubMed ID: 15317573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical decision support tools: performance of personal digital assistant versus online drug information databases.
    Clauson KA; Polen HH; Marsh WA
    Pharmacotherapy; 2007 Dec; 27(12):1651-8. PubMed ID: 18041886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External quality assurance committee for drug information services.
    Smith CJ; Sylvia LM
    Am J Hosp Pharm; 1990 Apr; 47(4):787-91. PubMed ID: 2321653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Newly-developed drug information services provided by hospital pharmacists].
    Hirota Y
    Rinsho Byori; 2003 Apr; 51(4):341-6. PubMed ID: 12747257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survey of consumer users of a statewide drug information service.
    Smith GH; Einarson TR
    Am J Hosp Pharm; 1985 Jul; 42(7):1557-61. PubMed ID: 4025353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Problems encountered in using written criteria to assess drug information responses.
    Wheeler-Usher DH; Hermann FF; Wanke LA
    Am J Hosp Pharm; 1990 Apr; 47(4):795-7. PubMed ID: 2321655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.